Ben Wolf
BW
Ben Wolf
Chief Medical Officer at Isomorphic Labs
Rate
About
Dr. Ben Wolf, M.D., Ph.D., is the Chief Medical Officer at Isomorphic Labs, Alphabet's AI-first drug discovery company. He brings nearly 20 years of biopharmaceutical experience, with deep expertise in precision oncology. Previously CMO at Relay Therapeutics and KSQ Therapeutics, and prior to that held senior clinical roles at Blueprint Medicines (where he helped bring Ayvakit™ and Gavreto™ to approval), Genentech, Amgen, and other leading biotech firms. He has authored over 40 peer-reviewed publications.
Frequently asked
Who is Ben Wolf?
Dr. Ben Wolf, M.D., Ph.D., is the Chief Medical Officer at Isomorphic Labs, Alphabet's AI-first drug discovery company. He brings nearly 20 years of biopharmaceutical experience, with deep expertise in precision oncology. Previously CMO at Relay Therapeutics and KSQ Therapeutics, and prior to that held senior clinical roles at Blueprint Medicines (where he helped bring Ayvakit™ and Gavreto™ to app…
What is Ben Wolf's current role?
Ben Wolf is currently Chief Medical Officer at Isomorphic Labs.
Comments
No comments yet. Be the first to share your take.
Profile
About Ben Wolf
Ben Wolf is Chief Medical Officer at Isomorphic Labs. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.